SCHEMBL499698

SCHEMBL499698

CCCCCCCCCCCCOC(=O)CCN1CCN(C)CC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 8/20 0.60
THRA P10827 5/20 0.60
NAAA Q02083 1/20 0.51
DGKA P23743 1/20 0.51
HTR2C P28335 1/20 0.50
NPC1 O15118 1/20 0.47
TP53 P04637 1/20 0.47
HPGD P15428 1/20 0.47
RAB9A P51151 1/20 0.47
PAOX Q6QHF9 1/20 0.46
MAPT P10636 1/20 0.46
RECQL P46063 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
PRSS1 P07477 1/20 0.46
PRSS2 P07478 1/20 0.46
PRSS3 P35030 1/20 0.46
RAD52 P43351 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
EPHX1 P07099 1/20 0.45
LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13601500 1.00 THRB (0.60) THRBTHRANAAADGKAHTR2C
SCHEMBL4979398 0.95 NAAA (0.56) THRBTHRANAAADGKAHTR2C
SCHEMBL11711713 0.95 NAAA (0.56) THRBTHRANAAADGKAHTR2C
SCHEMBL13601497 0.94 THRB (0.56) THRBTHRANAAADGKANPC1
SCHEMBL18068757 0.92 THRB (0.51) THRBTHRANAAADGKAHTR2C
SCHEMBL15848363 0.91 THRB (0.55) THRBTHRANAAADGKAHTR2C
SCHEMBL15848329 0.91 THRB (0.55) THRBTHRANAAADGKAHTR2C
SCHEMBL15848517 0.91 THRB (0.55) THRBTHRANAAADGKAHTR2C
SCHEMBL673095 0.89 DGKA (0.50) THRBTHRANAAADGKAHTR2C
SCHEMBL11598618 0.89 DGKA (0.50) THRBTHRANAAADGKAHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102348695-B Compositions and methods for inhibiting the agglomeration of hydrates in a process NALCO CO 2014-11-19 CN claimed
CN-102348695-B Compositions and methods for inhibiting the agglomeration of hydrates in a process NALCO CO 2014-11-19 CN disclosed
US-8334240-B2 Compositions and methods for inhibiting the agglomeration of hydrates in a process NALCO COMPANY (US) 2012-12-18 US disclosed
US-8334240-B2 Compositions and methods for inhibiting the agglomeration of hydrates in a process NALCO COMPANY (US) 2012-12-18 US disclosed
US-8329620-B2 Compositions and methods for inhibiting the agglomeration of hydrates NALCO COMPANY (US) 2012-12-11 US disclosed
US-8329620-B2 Compositions and methods for inhibiting the agglomeration of hydrates NALCO COMPANY (US) 2012-12-11 US disclosed
CN-102348695-A Compositions and methods for inhibiting the agglomeration of hydrates in a process NALCO CO 2012-02-08 CN disclosed
US-8105987-B2 Corrosion inhibitors for an aqueous medium NALCO COMPANY (US) 2012-01-31 US disclosed
US-8105988-B2 Corrosion inhibitors for a fluid NALCO COMPANY (US) 2012-01-31 US disclosed
US-8105988-B2 Corrosion inhibitors for a fluid NALCO COMPANY (US) 2012-01-31 US disclosed
WO-2010104727-A1 COMPOSITIONS AND METHODS FOR INHIBITING THE AGGLOMERATION OF HYDRATES IN A PROCESS NALCO COMPANY (US) 2010-09-16 WO disclosed
WO-2010042482-A1 COMPOSITIONS AND METHODS FOR INHIBITING THE AGGLOMERATION OF HYDRATES NALCO COMPANY (US) 2010-04-15 WO disclosed
US-20100087338-A1 COMPOSITIONS AND METHODS FOR INHIBITING THE AGGLOMERATION OF HYDRATES US SYNTHETIC CORPORATION 2010-04-08 US disclosed
US-20100087338-A1 COMPOSITIONS AND METHODS FOR INHIBITING THE AGGLOMERATION OF HYDRATES US SYNTHETIC CORPORATION 2010-04-08 US disclosed
US-20100087339-A1 COMPOSITIONS AND METHODS FOR INHIBITING THE AGGLOMERATION OF HYDRATES IN A PROCESS APERGY BMCS ACQUISITION CORP 2010-04-08 US disclosed
US-20100087339-A1 COMPOSITIONS AND METHODS FOR INHIBITING THE AGGLOMERATION OF HYDRATES IN A PROCESS APERGY BMCS ACQUISITION CORP 2010-04-08 US disclosed
US-20100084611-A1 CORROSION INHIBITORS FOR AN AQUEOUS MEDIUM NORRISEAL-WELLMARK, INC. 2010-04-08 US disclosed
US-20100084611-A1 CORROSION INHIBITORS FOR AN AQUEOUS MEDIUM NORRISEAL-WELLMARK, INC. 2010-04-08 US disclosed
US-20100084612-A1 CORROSION INHIBITORS FOR A FLUID CHAMPIONX LLC 2010-04-08 US disclosed
US-20100084612-A1 CORROSION INHIBITORS FOR A FLUID CHAMPIONX LLC 2010-04-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087339-A1 COMPOSITIONS AND METHODS FOR INHIBITING THE AGGLOMERATION OF HYDRATES IN A PROCESS AQP1, AQP3, AQP4 THRB 4425/4885THRA 4666/4885NAAA 1018/4885
US-20100087338-A1 COMPOSITIONS AND METHODS FOR INHIBITING THE AGGLOMERATION OF HYDRATES AQP1, AQP3, ABCB7 THRB 4286/4885THRA 4604/4885NAAA 447/4885
US-20100084611-A1 CORROSION INHIBITORS FOR AN AQUEOUS MEDIUM TFPI, TFPI2, GANAB THRB 3513/4885THRA 4481/4885NAAA 738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.